436 related articles for article (PubMed ID: 12522680)
21. Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.
Ahl J; Kinon BJ; Liu-Seifert H
Ann N Y Acad Sci; 2004 Dec; 1032():289-90. PubMed ID: 15677431
[TBL] [Abstract][Full Text] [Related]
22. [Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].
Konarzewska B; Szulc A; Popławska R; Galińska B; Juchnowicz D
Psychiatr Pol; 2008; 42(1):87-95. PubMed ID: 18567406
[TBL] [Abstract][Full Text] [Related]
23. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
24. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.
Melkersson K
J Clin Psychiatry; 2005 Jun; 66(6):761-7. PubMed ID: 15960571
[TBL] [Abstract][Full Text] [Related]
25. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
[TBL] [Abstract][Full Text] [Related]
27. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
[TBL] [Abstract][Full Text] [Related]
28. Quetiapine, an atypical antipsychotic.
Goren JL; Levin GM
Pharmacotherapy; 1998; 18(6):1183-94. PubMed ID: 9855315
[TBL] [Abstract][Full Text] [Related]
29. Switching antipsychotics: an updated review with a focus on quetiapine.
Weiden PJ
J Psychopharmacol; 2006 Jan; 20(1):104-18. PubMed ID: 16204323
[TBL] [Abstract][Full Text] [Related]
30. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
31. Quetiapine in adolescent psychosis.
Healy E; Subotsky F; Pipe R
J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1329. PubMed ID: 10560217
[No Abstract] [Full Text] [Related]
32. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
33. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
Kopecek M; Bares M; Horacek J; Mohr P
Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
[TBL] [Abstract][Full Text] [Related]
34. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
Stamouli S; Lykouras L
J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
[TBL] [Abstract][Full Text] [Related]
35. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics.
Chen CK; Huang YS; Ree SC; Hsiao CC
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1495-9. PubMed ID: 20732372
[TBL] [Abstract][Full Text] [Related]
36. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
37. Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Roke Y; Buitelaar JK; Boot AM; Tenback D; van Harten PN
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):432-9. PubMed ID: 23234586
[TBL] [Abstract][Full Text] [Related]
38. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
[TBL] [Abstract][Full Text] [Related]
39. Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
Montalvo I; Ortega L; López X; Solé M; Monseny R; Franch J; Vilella E; Labad J
Int Clin Psychopharmacol; 2013 Jan; 28(1):46-9. PubMed ID: 23232756
[TBL] [Abstract][Full Text] [Related]
40. [Galactorrhea and secondary amenorrhea in hyperprolactinemia].
Wallmeroth A; Staub JJ
Praxis (Bern 1994); 2000 Aug; 89(34):1341-3. PubMed ID: 11021189
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]